Nu-Med Plus (NUMD) Amortization of Deferred Charges (2013 - 2014)
Nu-Med Plus' (NUMD) quarterly Amortization of Deferred Charges came in at $30716.0 in Q1 2014, down 7.62% quarter-over-quarter from $33248.0 in Q4 2013.
Powered by 
Analysis
Nu-Med Plus (NUMD) Amortization of Deferred Charges (2013 - 2014) Analysis & Trends
Nu-Med Plus has disclosed Amortization of Deferred Charges across 2 years of filings, most recently posting $30716.0 for Q1 2014.
- In Q1 2014, Amortization of Deferred Charges changed N/A year-over-year to $30716.0; the TTM figure through Dec 2014 stood at $30716.0 (down 63.58% YoY), while the FY2014 annual figure was $30716.0, down 63.58% from the prior year.
- Amortization of Deferred Charges came in at $30716.0 for Q1 2014 at Nu-Med Plus, down from $33248.0 in the prior quarter.
- In the past five years, Amortization of Deferred Charges ranged from a high of $51086.0 in Q3 2013 to a low of $30716.0 in Q1 2014.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 179.79 Bn | 174.18 Bn | 7.27 Bn |
| 2 | Intuitive Surgical | 127.69 Bn | 122.47 Bn | 1.96 Bn |
| 3 | Medtronic | 117.23 Bn | 108.41 Bn | 6.34 Bn |
| 4 | Stryker | 103.55 Bn | 100.07 Bn | 4.50 Bn |
| 5 | Boston Scientific | 63.24 Bn | 62.70 Bn | 3.85 Bn |
| 6 | Edwards Lifesciences | 49.97 Bn | 45.72 Bn | 1.35 Bn |
| 7 | Alcon | 32.83 Bn | 31.37 Bn | 1.68 Bn |
| 8 | Dexcom | 32.30 Bn | 30.35 Bn | 830.00 Mn |
| 9 | Steris | 20.73 Bn | 20.25 Bn | 684.20 Mn |
| 10 | Nu-Med Plus | 1.67 Mn | 1.67 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2014 | 30,716.00 |
| Dec 31, 2013 | 33,248.00 |
| Sep 30, 2013 | 51,086.00 |